Form 4: Director Melissa Epperly Increases Stake in Roivant
Statement of Changes in Beneficial Ownership
Director Melissa B. Epperly acquired 670 common shares of Roivant Sciences Ltd. as part of the company's non-employee director compensation plan.
Summary
- Director Melissa B. Epperly received an award of 670 common shares.
- The shares were granted under the Issuer's Non-Employee Director Compensation Plan.
- The shares were fully vested upon the grant date of April 17, 2026.
- Following this transaction, the director's total beneficial ownership is 16,474 common shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.
Positives
- Director alignment with shareholder interests is reinforced through increased equity ownership.
Negatives
- None identified.
Risks
- None identified.
Future Outlook
Not applicable as this is a routine director compensation disclosure.
Industry Context
StockSavvy.ai notes that routine equity grants to non-employee directors are standard corporate governance practices in the biotechnology sector to ensure board members maintain a vested interest in long-term company performance.
Comparison to Industry Standards
- The grant is consistent with standard equity-based compensation packages for independent directors in mid-cap biopharmaceutical companies.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Grant of common shares under the Non-Employee Director Compensation Plan. | 04/17/2026 | Minimal; standard alignment of director interests. |
Stakeholder Impact
- Positive alignment for shareholders as directors increase their equity stake.
Next Steps
- No further actions required.
Key Dates
| Date | Description |
|---|---|
| 04/17/2026 | Date of the transaction and grant of common shares. |
| 04/21/2026 | Date of filing the Form 4. |
Keywords
Roivant Sciences, ROIV, Insider Trading, Director Compensation, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.